XML 30 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Common Share
Additional Paid-in Capital
Statutory Surplus
Retained Earnings (Accumulated Deficits)
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Total
Balance at Jun. 30, 2018 $ 1,359 $ 17,285,543 $ 1,118,467 $ (524,618) $ (401,677) $ 676,282 $ 18,155,356
Balance (in Shares) at Jun. 30, 2018 13,590,000            
Net income (loss) for the year (3,269,776) (162,813) (3,432,589)
Appropriation of statutory reserve 715,335 (715,335)
Foreign currency translation adjustments (411,973) (17,375) (429,348)
Stock-based compensation expense $ 22 7,016,089   7,016,111
Stock-based compensation expense (in Shares) 223,821            
Exercise of warrants $ 10 (10)  
Exercise of warrants (in Shares) 99,380            
Noncontrolling interests through an acquisition 64,879 64,879
Sale of subsidiaries’ shares to noncontrolling interests 47,189 47,189
Other (25,000) (25,000)
Balance at Jun. 30, 2019 $ 1,391 24,276,622 1,833,802 (4,509,729) (813,650) 608,162 21,396,598
Balance (in Shares) at Jun. 30, 2019 13,913,201            
Net income (loss) for the year 2,938,239 141,139 3,079,378
Cumulative effect of adopting ASC 606 (138,644) (138,644)
Purchase of subsidiaries’ shares from noncontrolling interests shareholders $ 10 (131,002) 130,992
Purchase of subsidiaries’ shares from noncontrolling interests shareholders (in Shares) 100,000            
Exercise of share options and vesting of restricted shares $ 183 (183)
Exercise of share options and vesting of restricted shares (in Shares) 1,830,514            
Acquisition of subsidiaries $ 9 436,531 411,351 847,891
Acquisition of subsidiaries (in Shares) 86,615            
Appropriation of statutory reserve 970,009 (970,009)
Foreign currency translation adjustments (549,015) (22,928) (571,943)
Stock-based compensation expense 4,004,080 4,004,080
Balance at Jun. 30, 2020 $ 1,593 28,586,048 2,803,811 (2,680,143) (1,362,665) 1,268,716 28,617,360
Balance (in Shares) at Jun. 30, 2020 15,930,330            
Net income (loss) for the year 6,816,572 202,643 7,019,215
Foreign currency translation loss 2,592,748 102,475 2,695,223
Purchase of subsidiaries’ shares from noncontrolling interests shareholders $ 6 3,274 (458,826) (455,546)
Purchase of subsidiaries’ shares from noncontrolling interests shareholders (in Shares) 62,622            
Disposal of subsidiarie (34,116) (34,116)
Exercise of share options and vesting of restricted shares $ 157 116,073 116,230
Exercise of share options and vesting of restricted shares (in Shares) 1,568,392            
Issuance of common shares from private placement $ 267 11,131,562 11,131,829
Issuance of common shares from private placement (in Shares) 2,666,666            
Warrants issued in connection with private placement 3,551,048 3,551,048
Dividends paid to noncontrolling interests (34,137) (34,137)
Appropriation of statutory reserve 1,410,264 (1,410,264)
Stock-based compensation expense 5,128,696 5,128,696
Exercise of warrants $ 6 (6)
Exercise of warrants (in Shares) 65,542            
Noncontrolling interests through an acquisition (5,107) (5,107)
Balance at Jun. 30, 2021 $ 2,029 $ 48,516,695 $ 4,214,075 $ 2,726,165 $ 1,230,083 $ 1,041,648 $ 57,730,695
Balance (in Shares) at Jun. 30, 2021 20,293,552